Expression of concern
A Rational Diagnostic Algorithm for the Identification of ALK Rearrangement in Lung Cancer: A Comprehensive Study of Surgically Treated Japanese Patients
Paper Information
Expression of concern Details
Retraction Reason:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1371/journal.pone.0278808Citations (38)
38
Total Citations0
Post-Retraction37
Pre-Retraction1
Same DayExpression of Concern: A Rational Diagnostic Algorithm for the Identification of ALK Rearrangement in Lung Cancer: A Comprehensive Study of Surgically Treated Japanese Patients
Unknown Authors
PLoS ONE
Open Access
Published: Jan 2023
Same day as retraction
The Impact of Estrogen Receptor Expression on Mutational Status in the Evolution of Non-Small Cell Lung Cancer
Yoko Tani, Hiroyasu Kaneda, Yasuhiro Koh et al. (12 authors)
Clinical Lung Cancer
Open Access
Published: Dec 2022
3 citations
3 citations
11 days before retraction
Prognostic impact and distinctive characteristics of surgically resected anaplastic lymphoma kinase–rearranged lung adenocarcinoma
Yosuke Matsuura, Hironori Ninomiya, Junji Ichinose et al. (7 authors)
Journal of Thoracic and Cardiovascular Surgery
Open Access
Published: Oct 2020
13 citations
13 citations
825 days before retraction
Clinicopathological characteristics of lung adenocarcinoma with compound EGFR mutations
Takuo Hayashi, Shinji Kohsaka, Kazuya Takamochi et al. (12 authors)
Human Pathology
Published: Jul 2020
9 citations
9 citations
911 days before retraction
Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using <scp>next‐generation</scp> sequencing technique
Saki Manabe, Rika Kasajima, Shuji Murakami et al. (10 authors)
Thoracic Cancer
Open Access
Published: Jun 2020
11 citations
11 citations
932 days before retraction
Impact of somatic mutations on prognosis in resected non‐small‐cell lung cancer: The Japan Molecular Epidemiology for lung cancer study
Akihiro Tamiya, Yasuhiro Koh, Shun‐ichi Isa et al. (18 authors)
Cancer Medicine
Open Access
Published: Feb 2020
13 citations
13 citations
1071 days before retraction
Development of a Novel One-Step Automated Rapid in situ Hybridization for Anaplastic Lymphoma Kinase Rearrangement Using Non-Contact Alternating-Current Electric-Field Mixing
Kazuhiro Imai, Shinogu Takashima, Satoshi Fujishima et al. (13 authors)
Pathobiology
Open Access
Published: Jan 2020
1 citation
1 citation
1106 days before retraction
CT Characteristics of Non–Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangement: A Systematic Review and Meta-Analysis
Tae‐Hyung Kim, Sungmin Woo, Soon Ho Yoon et al. (6 authors)
American Journal of Roentgenology
Open Access
Published: Aug 2019
14 citations
14 citations
1245 days before retraction
Fluorescence in Situ Hybridization (FISH) for Detecting Anaplastic Lymphoma Kinase (ALK) Rearrangement in Lung Cancer: Clinically Relevant Technical Aspects
Zhenya Tang, Lu Wang, Guilin Tang et al. (4 authors)
International Journal of Molecular Sciences
Open Access
Published: Aug 2019
37 citations
37 citations
1247 days before retraction
ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
Gina Rosas, Rossana Ruiz, Jhajaira M. Araujo et al. (5 authors)
Critical Reviews in Oncology/Hematology
Published: Feb 2019
46 citations
46 citations
1425 days before retraction
The classification of lung cancers and their degree of malignancy by FTIR, PCA-LDA analysis, and a physics-based computational model
Ewa Kaznowska, Joanna Depciuch, Kornelia Łach et al. (9 authors)
Talanta
Published: Apr 2018
72 citations
72 citations
1720 days before retraction
Novel method for rapid fluorescence in-situ hybridization of ALK rearrangement using non-contact alternating current electric field mixing
Satoshi Fujishima, Kazuhiro Imai, Ryuta Nakamura et al. (11 authors)
Scientific Reports
Open Access
Published: Nov 2017
7 citations
7 citations
1895 days before retraction
RT-PCR for Detecting ALK Translocations in Cytology Samples from Lung Cancer Patients
Shinji Nakamichi, Masahiro Seike, Akihiko Miyanaga et al. (11 authors)
Anticancer Research
Open Access
Published: May 2017
10 citations
10 citations
2053 days before retraction
DNA mismatch repair deficiency in surgically resected lung adenocarcinoma: Microsatellite instability analysis using the Promega panel
Kazuya Takamochi, Fumiyuki Takahashi, Yoshiyuki Suehara et al. (12 authors)
Lung Cancer
Published: May 2017
67 citations
67 citations
2061 days before retraction
Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
Toyoaki Hida, Hiroshi Nokihara, Masashi Kondo et al. (23 authors)
The Lancet
Published: May 2017
838 citations
838 citations
2071 days before retraction
Assessment of <i>ALK</i> gene rearrangement in lung cancer using a new rapid automated SureFISH (Dako Omnis) assay
Maiko Takeda, Takahiko Kasai, Shigeki Shimizu et al. (11 authors)
Journal of Clinical Pathology
Published: Mar 2017
3 citations
3 citations
2137 days before retraction
Evaluating the effectiveness of <scp>RNA </scp><i>in‐situ</i> hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement
Naoki Nakajima, Akihiko Yoshizawa, Kyoko Kondo et al. (13 authors)
Histopathology
Published: Feb 2017
16 citations
16 citations
2148 days before retraction
Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects
Naoko Tsuyama, Kana Sakamoto, Seiji Sakata et al. (5 authors)
Journal of Clinical and Experimental Hematopathology
Open Access
Published: Jan 2017
101 citations
101 citations
2201 days before retraction
Does Immunohistochemistry Represent a Robust Alternative Technique in Determining Drugable Predictive Gene Alterations in Non-Small Cell Lung Cancer?
Giulio Rossi, Moira Ragazzi, Ione Tamagnini et al. (13 authors)
Current Drug Targets
Open Access
Published: Dec 2016
24 citations
24 citations
2231 days before retraction
ALK Immunohistochemistry for ALK Gene Rearrangement Screening in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Jung‐Soo Pyo, Guhyun Kang, Jin Hee Sohn
The International Journal of Biological Markers
Open Access
Published: Jun 2016
15 citations
15 citations
2391 days before retraction
Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study
Tomoya Kawaguchi, Yasuhiro Koh, Masahiko Ando et al. (20 authors)
Journal of Clinical Oncology
Published: May 2016
118 citations
118 citations
2437 days before retraction
Repeated biopsy results
Shingo Miyamoto
Japanese Journal of Clinical Oncology
Open Access
Published: Mar 2016
2 citations
2 citations
2500 days before retraction
Changes in Immunohistochemical Protein Levels in Anaplastic Lymphoma Kinase-positive Lung Adenocarcinoma Possibly due to Chemo-radiotherapy
Hirokazu Taniguchi, Takaya Ikeda, Hiroshi Soda et al. (7 authors)
Internal Medicine
Open Access
Published: Jan 2016
1 citation
1 citation
2567 days before retraction
Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)
Kengo Takeuchi, Yosuke Togashi, Yuki Kamihara et al. (18 authors)
Annals of Oncology
Open Access
Published: Oct 2015
54 citations
54 citations
2639 days before retraction
A Case of Squamous Cell Carcinoma Harboring an EML4-ALK Rearrangement that Was Unsuccessfully Treated with the ALK Inhibitor Alectinib
Akihiro Tamiya, Shigeki Shimizu, Shinji Atagi
Journal of Thoracic Oncology
Open Access
Published: Jul 2015
19 citations
19 citations
2729 days before retraction
Clinicopathological Characteristics of Patients with Non-Small-Cell Lung Cancer Who Harbor EML4-ALK Fusion Gene: A Meta-Analysis
Fengzhi Zhao, Meng Xu, Honcho Lei et al. (8 authors)
PLoS ONE
Open Access
Published: Feb 2015
52 citations
52 citations
2879 days before retraction
Clinical characteristics of patients with non-small cell lung cancers harboring anaplastic lymphoma kinase rearrangements and primary lung adenocarcinoma harboring epidermal growth factor receptor mutations
Lina Xu, Jian Lei, Q.Z. Wang et al. (5 authors)
Genetics and Molecular Research
Open Access
Published: Jan 2015
14 citations
14 citations
2932 days before retraction
The Role of Immunohistochemical Analysis in the Evaluation of EML4-ALK Gene Rearrangement in Lung Cancer
Harold C. Sullivan, Kevin E. Fisher, Anne L. Hoffa et al. (7 authors)
Applied immunohistochemistry & molecular morphology
Published: Sep 2014
21 citations
21 citations
3028 days before retraction
Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and Ultrasensitive Immunohistochemistry
Esther Conde, Ana Suárez‐Gauthier, Amparo Benito et al. (23 authors)
PLoS ONE
Open Access
Published: Sep 2014
65 citations
65 citations
3032 days before retraction
Evaluation of immunohistochemistry using two different antibodies and procedures for primary lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangement
Jun Akiba, Akihiko Kawahara, Hideyuki Abe et al. (15 authors)
Oncology Letters
Open Access
Published: Sep 2014
4 citations
4 citations
3047 days before retraction
Canadian Anaplastic Lymphoma Kinase Study: A Model for Multicenter Standardization and Optimization of ALK Testing in Lung Cancer
Jean‐Claude Cutz, Kenneth J. Craddock, Emina Torlakovic et al. (36 authors)
Journal of Thoracic Oncology
Open Access
Published: Aug 2014
77 citations
77 citations
3072 days before retraction
Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements
Yoon Jin, Jae Seok Lee, Hye Ryun Kim et al. (7 authors)
PLoS ONE
Open Access
Published: Jul 2014
74 citations
74 citations
3093 days before retraction
Clinicopathological and Demographical Characteristics of Non-Small Cell Lung Cancer Patients with ALK Rearrangements: A Systematic Review and Meta-Analysis
Fan Liang, Yun Feng, Wan Huan-ying et al. (5 authors)
PLoS ONE
Open Access
Published: Jun 2014
64 citations
64 citations
3123 days before retraction
Reflex ALK immunohistochemistry is feasible and highly specific for ALK gene rearrangements in lung cancer
Michelle Houang, Christopher W. Toon, Adele Clarkson et al. (12 authors)
Pathology
Published: May 2014
33 citations
33 citations
3162 days before retraction
Prognostic and predictive biomarkers in lung cancer. A review
Erik Thunnissen, Kimberly van der Oord, Michael den Bakker
Virchows Archiv
Published: Jan 2014
85 citations
85 citations
3285 days before retraction
Micro-cost Analysis of <i>ALK</i> Rearrangement Testing by FISH to Determine Eligibility for Crizotinib Therapy in NSCLC: Implications for Cost Effectiveness of Testing and Treatment
David M. Parker, Marc‐Antoine Belaud‐Rotureau
Clinical Medicine Insights Oncology
Open Access
Published: Jan 2014
6 citations
6 citations
3297 days before retraction
Comparison of In-house and Outsourced ALK Tests (IHC and FISH) in Patients with Lung Cancer
Tetsuya Isaka, Tomoyuki Yokose, Haruhiro Saito et al. (10 authors)
Haigan
Open Access
Published: Jan 2014
3297 days before retraction
Problems with the Diagnosis and Treatment of Patients with ALK-rearranged NSCLC in the Clinical Setting
Miyako Satouchi
Haigan
Open Access
Published: Jan 2014
3297 days before retraction
Quick Stats
Total Citations:
38
Years Since Retraction:
2.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025